These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16288078)
1. Myocardial infarction associated with intravenous immune globulin. Stenton SB; Dalen D; Wilbur K Ann Pharmacother; 2005 Dec; 39(12):2114-8. PubMed ID: 16288078 [TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis. Ririe MR; Blaylock RC; Morris SE; Jung JY J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282 [TBL] [Abstract][Full Text] [Related]
3. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion. Barsheshet A; Marai I; Appel S; Zimlichman E Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446 [TBL] [Abstract][Full Text] [Related]
4. Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration. Davé S; Hagan J Ann Allergy Asthma Immunol; 2007 Dec; 99(6):567-70. PubMed ID: 18219840 [TBL] [Abstract][Full Text] [Related]
5. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation. Chapman SA; Gilkerson KL; Davin TD; Pritzker MR Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143 [TBL] [Abstract][Full Text] [Related]
6. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases. Elkayam O; Paran D; Milo R; Davidovitz Y; Almoznino-Sarafian D; Zeltser D; Yaron M; Caspi D Ann Rheum Dis; 2000 Jan; 59(1):77-80. PubMed ID: 10627434 [TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases. Chen J; Wang B; Zeng Y; Xu H Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352 [TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options. Teo L; Tay YK; Liu TT; Kwok C Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Marie I; Maurey G; Hervé F; Hellot MF; Levesque H Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420 [TBL] [Abstract][Full Text] [Related]
10. [Dipyridamole Tc-99m MIBI myocardial perfusion scintigraphy in patients with post-infarction chest pain symptom]. Yang CC; Wu CC; Jong SB Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):605-17. PubMed ID: 1296041 [TBL] [Abstract][Full Text] [Related]
11. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC; J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772 [TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin, blood viscosity and myocardial infarction. Fisman DN; Smilovitch M Can J Cardiol; 1997 Aug; 13(8):775-7. PubMed ID: 9284845 [TBL] [Abstract][Full Text] [Related]
13. Acute stroke with high-dose intravenous immune globulin. White DA; Leonard MC Am J Health Syst Pharm; 2007 Aug; 64(15):1611-4. PubMed ID: 17646563 [TBL] [Abstract][Full Text] [Related]
14. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Lee HY; Pang SM; Thamotharampillai T J Am Acad Dermatol; 2008 Aug; 59(2):352-3. PubMed ID: 18638633 [No Abstract] [Full Text] [Related]
15. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population. Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531 [TBL] [Abstract][Full Text] [Related]
16. Intravenous immune globulin (IVIG) precipitating acute myocardial infarction. Struble EJ; Dice YG J Miss State Med Assoc; 2002 Apr; 43(4):115. PubMed ID: 11989198 [No Abstract] [Full Text] [Related]
17. A case of toxic epidermal necrolysis induced by allopurinol with human herpesvirus-6 reactivation. Watanabe Y; Matsukura S; Isoda Y; Morita A; Aihara M; Kambara T Acta Derm Venereol; 2013 Nov; 93(6):731-2. PubMed ID: 23604033 [No Abstract] [Full Text] [Related]
18. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695 [TBL] [Abstract][Full Text] [Related]
19. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Yang Y; Xu J; Li F; Zhu X Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Khalili B; Bahna SL Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]